BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Borgerding MP, Absher RK, So TY. Tramadol use in pediatric sickle cell disease patients with vaso-occlusive crisis. World J Clin Pediatr 2013; 2(4): 65-69 [PMID: 25254176 DOI: 10.5409/wjcp.v2.i4.65]
URL: https://www.wjgnet.com/2219-2808/full/v2/i4/65.htm
Number Citing Articles
1
Frédérique Rodieux, Laszlo Vutskits, Klara M. Posfay-Barbe, Walid Habre, Valérie Piguet, Jules A. Desmeules, Caroline F. Samer. When the Safe Alternative Is Not That Safe: Tramadol Prescribing in ChildrenFrontiers in Pharmacology 2018; 9 doi: 10.3389/fphar.2018.00148
2
F. Rodieux, M. Besson, V. Piguet, J. Desmeules, C. Samer. Prescription de tramadol chez les enfants : une bonne alternative à la codéine ?Douleur et Analgésie 2020; 33(4): 247 doi: 10.3166/dea-2020-0139
3
Narjeet Khurmi, Andrew Gorlin, Lopa Misra. Perioperative considerations for patients with sickle cell disease: a narrative reviewCanadian Journal of Anesthesia/Journal canadien d'anesthésie 2017; 64(8): 860 doi: 10.1007/s12630-017-0883-3
4
Bhaskar V.K.S. Lakkakula, Radharani Sahoo, Henu Verma, Saikrishna Lakkakula. Pain Management Issues as Part of the Comprehensive Care of Patients with Sickle Cell DiseasePain Management Nursing 2018; 19(6): 558 doi: 10.1016/j.pmn.2018.06.004